@ginny_crisp CVS removed Stelara from the formulary. Through its specialized subsidiary, Cordavis, CVS partners with Samsung Bioepis to distribute a co-branded, private-label version of biosimilar Pyzchiva. Yesintek is in formulary but being denied.
@elonmusk In the form of a Model X, which I would have kept buying forever. Let me know when you decide to sell a luxury car again. I'll be your first buyer.
@joelsstafford I work for Google. Two weeks ago I sent Argon after a systems bug our test grids picked up once or twice a quarter that could trigger a machine check. What impressed me (after my shock that it succeeded) was the depth of analysis down into cycle counts.
@mattyglesias It's a trillions to billions join problem. Google's systems do this kind of thing relatively easily...but you need to walk the graph. You need some good old fashioned non AI scaled cluster analysis.
@TexasOncologist Some non-household names are doing great writing on Pharmacy Benefit Managers chicanery. See @ginny_crisp for a long, long list of ways they do it.
@danluu When using permissive models, having *independent agents* check the validity of repros is critical. You must also do independent verification and analysis of remediations to defend against misaligned permissive models.
@Sardor_Rahim@danluu You really, really need to check the repros made by permissive models. Even when they reproduce a flaw, that may not be the only thing they do.